Wells Fargo
APYX icon

Wells Fargo’s Apyx Medical APYX Stock Holding History

Wells Fargo’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,500
Closed -$5.25K – 7178
2025
Q4 		$5.25K Buy
+1,500
New +$5.23K ﹤0.01% 6086
2024
Q2 		– Sell
-236
Closed -$321 – 6897
2024
Q1 		$321 Buy
236
+3
+1% +$6 ﹤0.01% 6384
2023
Q4 		$609 Buy
233
+13
+6% +$31 ﹤0.01% 6338
2023
Q3 		$704 Buy
220
+3
+1% +$14 ﹤0.01% 6286
2023
Q2 		$1.09K Buy
217
+9
+4% +$46 ﹤0.01% 6303
2023
Q1 		$599 Buy
208
+3
+1% +$9 ﹤0.01% 6510
2022
Q4 		$480 Buy
205
+5
+3% +$15 ﹤0.01% 6398
2022
Q3 		$1K Sell
200
-3
-1% -$21 ﹤0.01% 6262
2022
Q2 		$1K Sell
203
-21,479
-99% -$110K ﹤0.01% 6454
2022
Q1 		$142K Sell
21,682
-44,922
-67% -$442K ﹤0.01% 5154
2021
Q4 		$853K Sell
66,604
-48,954
-42% -$685K ﹤0.01% 4242
2021
Q3 		$1.6M Buy
115,558
+1,374
+1% +$14.5K ﹤0.01% 3860
2021
Q2 		$1.18M Buy
114,184
+30,950
+37% +$307K ﹤0.01% 4097
2021
Q1 		$803K Sell
83,234
-16,965
-17% -$170K ﹤0.01% 4396
2020
Q4 		$721K Buy
100,199
+8,379
+9% +$55.5K ﹤0.01% 4261
2020
Q3 		$432K Sell
91,820
-47,723
-34% -$236K ﹤0.01% 4455
2020
Q2 		$775K Buy
139,543
+23,933
+21% +$99.5K ﹤0.01% 4012
2020
Q1 		$415K Buy
115,610
+42,700
+59% +$287K ﹤0.01% 4179
2019
Q4 		$617K Sell
72,910
-1,397
-2% -$10.1K ﹤0.01% 4199
2019
Q3 		$503K Buy
74,307
+36,169
+95% +$257K ﹤0.01% 4376
2019
Q2 		$256K Sell
38,138
-106,121
-74% -$577K ﹤0.01% 4832
2019
Q1 		$910K Sell
144,259
-42,366
-23% -$328K ﹤0.01% 3943
2018
Q4 		$1.21M Sell
186,625
-25,229
-12% -$153K ﹤0.01% 3698
2018
Q3 		$1.5M Buy
211,854
+135,822
+179% +$755K ﹤0.01% 3651
2018
Q2 		$331K Buy
76,032
+50,672
+200% +$187K ﹤0.01% 4737
2018
Q1 		$75K Sell
25,360
-1,125
-4% -$2.9K ﹤0.01% 5425
2017
Q4 		$68K Buy
26,485
+17,045
+181% +$53.2K ﹤0.01% 5444
2017
Q3 		$32K Buy
+9,440
New +$24.4K ﹤0.01% 5590
2016
Q2 		– Sell
-1
Closed – – 6080
2016
Q1 		$0 Hold
1
– – ﹤0.01% 6176
2015
Q4 		$0 Sell
1
-1,000
-100% -$1.93K ﹤0.01% 6199
2015
Q3 		$2K Buy
1,001
+1,000
+100,000% +$2.29K ﹤0.01% 5972
2015
Q2 		$0 Hold
1
– – ﹤0.01% 6327
2015
Q1 		$0 Hold
1
– – ﹤0.01% 6151
2014
Q4 		$0 Hold
1
– – ﹤0.01% 6196
2014
Q3 		$0 Hold
1
– – ﹤0.01% 6162
2014
Q2 		$0 Hold
1
– – ﹤0.01% 6093
2014
Q1 		$0 Hold
1
– – ﹤0.01% 5856
2013
Q4 		$0 Hold
1
– – ﹤0.01% 5720
2013
Q3 		$0 Hold
1
– – ﹤0.01% 5637
2013
Q2 		$0 Buy
+1
New +$3 ﹤0.01% 5560

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Wells Fargo's APYX Position: Q1 2026 in Review

Wells Fargo sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 1,500 shares — an estimated $5.25K sold.

Wells Fargo first reported a position in APYX in Q2 2013 and held it in 40 quarters. The position peaked at $1.6M in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Wells Fargo reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 1,500 Apyx Medical shares in Q1 2026, an estimated $5.25K.
  • Wells Fargo first reported a position in Apyx Medical in Q2 2013 and held it in 40 quarters.
  • Wells Fargo's Apyx Medical position peaked at $1.6M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.